Committed $168 million across three malaria research grants — triggering a sixfold rise in global malaria funding

The Gates Foundation committed $168 million across three concentrated malaria research grants covering vaccine development, new drug candidates, and innovative mosquito control. The investment helped catalyse a near-sixfold increase in global malaria funding over the decade that followed — with malaria cases and deaths beginning to fall substantially from 2005 onward for the first time in decades. Researchers credited the influx of private philanthropic capital with re-energising a field that had been chronically underfunded relative to its disease burden.